Quantifying Hepatic Mitochondrial Fluxes in Humans

Abroad (travel likely)RecruitingPHASE4

Conditions

Non-Alcoholic Fatty Liver Disease · Type 2 Diabetes · Mitochondrial Metabolism Disorders

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Texas Diabetes Institute - University Health System, San Antonio, Texas, United States
Contact: Study coordinator (Andrea Hansis-Diarte, MPh) · hansisdiarte@uthscsa.edu · 210-567-6691
Contact: Study coordinator (Luke Norton, PhD) · hansisdiarte@uthscsa.edu · 210-567-0739
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Study leads

Luke Norton, PhD
Principal Investigator
The University of Texas Health Science Center at San Antonio

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

Obesity and Type 2 Diabetes · NAFLD - Non-Alcoholic Fatty Liver Disease · Hypertension

Abroad (travel likely)Recruiting

Singapore, Singapore

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Non-alcoholic Fatty Liver Disease

Abroad (travel likely)RecruitingPHASE3

Arcadia, United States · Covina, United States

Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD

Non-Alcoholic Fatty Liver Disease

Abroad (travel likely)Recruiting

Québec, Canada

A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

Fatty Liver Disease

Abroad (travel likely)RecruitingPHASE1

Montreal, Canada